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Abstract 
Background 
Disease severity scores such as CURB-65 are often used to guide the management of 
patients with community-acquired pneumonia. Early and adequate empirical antibiotic 
treatment reduces mortality. The aim of this study was to examine the severity 
assessment and management of patients presenting with community-acquired 
pneumonia at the European Gaza Hospital in the Gaza Strip and to compare this to the 
best available evidence. 
Methods 
Medical records of all patients admitted to the European Gaza Hospital with a diagnosis 
of community-acquired pneumonia between Dec 1, 2015, and March 31, 2016, were 
reviewed retrospectively. Clinical practice was compared with recommendations for 
severity assessment and the management of community-acquired pneumonia, as 
reported in guidelines by the National Institute for Health and Care Excellence and the 
American Thoracic Society. Ethical approval was obtained from the General Directorate 
of Human Resources. 
Findings 
141 patients were admitted to the European Gaza Hospital with community-acquired 
pneumonia during the study period. Records of 41 patients were missing or could not be 
retrieved. The mean age of patients was 55·9 years (SD 20·2). Blood urea and nitrogen 
concentrations were not documented for 48 (48%) patients, and respiratory rate was not 
documented for 73 (73%) patients. The CURB-65 score was determined only for 12 
(12%) patients. Microbiological testing was done only for two (2%) patients. Although 18 
different antibiotic regimens were used, 81 (81%) patients received a β-lactam plus 
macrolide combination therapy, either given alone (49 [49%] patients) or with another 
antibiotic (32 [32%] patients), which is in line with the recommendations for patients 
admitted to hospital with community-acquired pneumonia. 43 (43%) patients received 
anti-viral drugs, and 41 (41%) patients received corticosteroids. 
Interpretation 
Clinicians were poorly adherent to current standards of care in severity assessment and 
management of community-acquired pneumonia. Moreover, the broad range of 
antibiotic regimes used, without microbiological guidance, was inappropriate and will 
have increased the risk of antibiotic resistance. A local evidence-based clinical practice 
guideline should be developed and implemented. Furthermore, the documentation 
system should be improved to enhance the continuity of care and clinical auditing. 
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